Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides

被引:64
作者
Liu, Yarong [1 ]
Kim, Young Joo [2 ]
Ji, Man [3 ]
Fang, Jinxu [1 ]
Siriwon, Natnaree [1 ]
Zhang, Li I. [2 ]
Wang, Pin [1 ,4 ,5 ]
机构
[1] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Dept Physiol & Biophys, Los Angeles, CA USA
[3] Univ Southern Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA
[4] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA USA
[5] Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
GUINEA-PIG COCHLEA; INTRACELLULAR TRAFFICKING; MEMBRANE-FUSION; FACTOR-IX; TYPE-2; VECTORS; TRANSDUCTION; PROTEIN; MUSCLE; INFECTION;
D O I
10.1038/mtm.2013.12
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adeno-associated virus type 2 (AAV2) is considered a promising gene delivery vector and has been extensively applied in several disease models; however, inefficient transduction in various cells and tissues has limited its widespread application in many areas of gene therapy. In this study, we have developed a general, but efficient, strategy to enhance viral transduction, both in vitro and in vivo, by incubating viral particles with cell-permeable peptides (CPPs). We show that CPPs increase internalization of viral particles into cells by facilitating both energy-independent and energy-dependent endocytosis. Moreover, CPPs can significantly enhance the endosomal escape process of viral particles, thus enhancing viral transduction to those cells that have exhibited very low permissiveness to AAV2 infection as a result of impaired intracellular viral processing. We also demonstrated that this approach could be applicable to other AAV serotypes. Thus, the membrane-penetrating ability of CPPs enables us to generate an efficient method for enhanced gene delivery of AAV vectors, potentially facilitating its applicability to human gene therapy.
引用
收藏
页数:13
相关论文
共 56 条
  • [31] Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice
    Nakai, H
    Fuess, S
    Storm, TA
    Muramatsu, S
    Nara, Y
    Kay, MA
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (01) : 214 - 224
  • [32] Filipin-dependent inhibition of cholera toxin: Evidence for toxin internalization and activation through caveolae-like domains
    Orlandi, PA
    Fishman, PH
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 141 (04) : 905 - 915
  • [33] Pack DW, 2000, BIOTECHNOL BIOENG, V67, P217, DOI 10.1002/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.3.CO
  • [34] 2-H
  • [35] Mutant Rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment
    Press, B
    Feng, Y
    Hoflack, B
    Wandinger-Ness, A
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 140 (05) : 1075 - 1089
  • [36] Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells
    Rudolph, C
    Plank, C
    Lausier, J
    Schillinger, U
    Müller, RH
    Rosenecker, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) : 11411 - 11418
  • [37] Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation
    Sanlioglu, S
    Benson, PK
    Yang, JS
    Atkinson, EM
    Reynolds, T
    Engelhardt, JF
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (19) : 9184 - 9196
  • [38] Real-time single-molecule imaging of the infection pathway of an adeno-associated virus
    Seisenberger, G
    Ried, MU
    Endress, T
    Büning, H
    Hallek, M
    Bräuchle, C
    [J]. SCIENCE, 2001, 294 (5548) : 1929 - 1932
  • [39] RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism
    Shi, WF
    Bartlett, JS
    [J]. MOLECULAR THERAPY, 2003, 7 (04) : 515 - 525
  • [40] Quantification of adeno-associated virus particles and empty capsids by optical density measurement
    Sommer, JM
    Smith, PH
    Parthasarathy, S
    Isaacs, J
    Vijay, S
    Kieran, J
    Powell, SK
    McClelland, A
    Wright, JF
    [J]. MOLECULAR THERAPY, 2003, 7 (01) : 122 - 128